Association of 2 prostatic tumors
Zabala-Egurrola, J.A.; Pertusa Peña, C.; del Tanago, J.G.; Llarena Ibarguren, R.; Arruza Etxebarriá, A.; Arregui Erbina, P.
Archivos Espanoles de Urologia 42(6): 583-586
1989
ISSN/ISBN: 0004-0614 PMID: 2817992 Document Number: 337320
We report on a case of primary transitional cell carcinoma of the prostate associated with focal prostatic carcinoma, incidentally discovered after TUR of the prostate. An underlying bladder tumor was discarded by randomized TUR of the bladder and serial cytologic analyses.
Document emailed within 1 workday
Related Documents
Plante, P.; Lesourd, A.; Blanchet, P.; Castagnola, C.; Coloby, P.; Daffer, N.; Davin, J.L.; Desgrandchamps, F.; Irani, J.; Marechal, J.M.; Mottet, N.; Pariente, J.L. 1998: Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(1): 47-50Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Reuter, H.J.; Schuck, W. 1971: Cryosurgery of prostatic and bladder tumors Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 42(9): 412-417
Reuter, H.J. 1978: Complications of cryosurgery in the treatment of prostatic tumors Archivos Espanoles de Urologia 31(3): 213-224
Gherlinzoni, F.; Picci, P. 1980: Association of Paget's disease with metastasis from a prostatic carcinoma in the same bone segment La Chirurgia Degli Organi di Movimento 66(5): 451-455
Chung, L.W.; Breitweiser, K. 1983: Comparison of soluble protein kinases from normal rat prostates and prostatic Dunning tumors Cancer Research 43(7): 3297-3304
Van Moorselaar, R.J.; Hendriks, B.T.; van Stratum, P.; van der Meide, P.H.; Debruyne, F.M.; Schalken, J.A. 1991: Synergistic antitumor effects of rat gamma-interferon and human tumor necrosis factor alpha against androgen-dependent and -independent rat prostatic tumors Cancer Research 51(9): 2329-2334
Molinié, V.; Vieillefond, A.; Cochand-Priollet, B.; Dauge-Geffroy, M.C.; Lefrère-Belda, M.A.; de Fromont, M.; Lesourd, A.; Toublanc, M.; Berger, N.; Bouvier, R.; Villers, A. 1999: Recommendations for reforming prostatic specimens. Les Membres du Sous-Comité Prostate du Comité de Cancerologie de l'Association Française d'Urologie Annales de Pathologie 19(6): 549-556
Jochmus, I. 1994: Human papillomaviruses (HPV) and its association with tumors of the ENT area Hno 42(11): 663-664
Nissen, E.D.; Kent, D.R.; Nissen, S.E.; McRae, D.M. 1976: Association of liver tumors with oral contraceptives Obstetrics and Gynecology 48(1): 49-55
Kondo, Y.; Sato, K.; Ohkawa, H.; Ueyama, Y.; Okabe, T.; Sato, N.; Asano, S.; Mori, M.; Ohsawa, N.; Kosaka, K. 1983: Association of hypercalcemia with tumors producing colony-stimulating factor(s) Cancer Research 43(5): 2368-2374
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Bouffioux, C. 1983: Prostatic cytology. Value of the technic in the diagnosis and surveillance of prostatic carcinomas; viewpoint of the urologist Acta Urologica Belgica 51(1): 56-71
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Cecchi, M.; Sepich, C.A.; Pagni, G.L.; Summonti, D.; Ippolito, C.; Di Benedetto, A.; Bertolini, L.; Minervini, R.; Fiorentini, L. 1998: Prostatic endoprosthesis in the treatment of prostatic obstruction: preliminary experience with the new Trestle model Chirurgia Italiana 50(1): 37-40
Vieillefond, A.; Berger, N.; Dauge-Geffroy, M.C.; Saint Andre, J.P. 1993: Prostatic adenosis and dysplasia. what is their definition... and their significance? Are there "precancerous" lesions in prostatic pathology? Annales de Pathologie 13(2): 85-87
Svanholm, H.; Hørder, M. 1988: Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques Scandinavian Journal of Urology and Nephrology. Supplementum 107: 65-70
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430